Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience

Mohsen Saleh Elalfy, MD, Tamer Hassan, MD, Khalid Elsayh, MD, Mohamed Maebid, MD, Hoda Hassab, MD, Rasha Elashry, MD, Mona El ghamrawy, MD, Mahmoud Elhawy, MD, Marwa Zakaria, MD, Mohamed Elshanshory, MD

Blood (2019) 134 (Supplement_1): 4907.

https://doi.org/10.1182/blood-2019-121994

Published: 2019

Journal Articles

Prevention and Management of Daratumumab Mediated Infusion Related Hypersensitivity Reactions Pre-and Post-Implementation of Rapid Infusion Protocol

My L Nguyen, PharmD, Catherine Burdalski, PharmD, BCOP, Syed Abbas Ali, MD, Lindsay Kohler, BS, PharmD Candidate, Steven Gilmore, PharmD, BCOP

Blood (2019) 134 (Supplement_1): 5811.

https://doi.org/10.1182/blood-2019-125391

Published: 2019

Journal Articles

Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center

Giuliana Giardino, Nesrine Radwan, Patra Koletsi, Deborah M. Morrogh, Stuart Adams, Winnie Ip, Austen Worth, Alison Jones, Imke Meyer-Parsonson, H. Bobby Gaspar, Kimberly Gilmour, E. Graham Davies, Fani Ladomenou

Blood (2019) 133 (24): 2586–2596.

https://doi.org/10.1182/blood.2018885244

Published: 2019

Journal Articles

Updated Preliminary Results of a Phase 1b Dose Escalation and Dose Expansion Study of Tirabrutinib Alone or in Combination with Idelalisib or Entospletinib in Patients with Previously Treated Chronic Lymphocytic Leukemia

Alexey V Danilov, MD PhD, Charles Herbaux, MD, Martin J.S. Dyer, MA, DPhil, FRCP, FRCPath, Peter Hillmen, MB ChB, PhD FRCP, FRCPath, Simon Rule, MD, Ebenezer A Kio, MD, Xi Huang, PhD, Siddhartha Mitra, MD PhD, Lionel Karlin, MD, Christopher Fegan, MD

Blood (2018) 132 (Supplement 1): 3135.

https://doi.org/10.1182/blood-2018-99-113111

Published: 2018

Journal Articles

Immunodeficiency Caused Byheterozygous RAG1 Gene Mutation in a Boy Manifested As Severe Granulomatous Diseases and Eosinophilia: A Case Report

Jing PAN, MD, Min Xiong, Jingjing Wang, Shan Wang, Zhuojun Ling, Jinlong Xu, Jiajia Duan, Gen Wang, Tong Wu, MD PhD, Chunrong Tong

Blood (2017) 130 (Supplement 1): 4828.

https://doi.org/10.1182/blood.V130.Suppl_1.4828.4828

Published: 2017

Journal Articles

Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (GEN503): Final Results of an Open-Label, Phase 1/2 Study

Torben Plesner, MD, Hendrik-Tobias Arkenau, Francesca Marianatal Gay, Monique C Minnema, Mario Boccadoro, Philippe Moreau, MDPhD, James D Cavenagh, Aurore Perrot, MD, Jacob Laubach, MD, Tahamtan Ahmadi, Carla de Boer, Diana Chen, Christopher Chiu, Jordan Schecter, Paul G Richardson, MD

Blood (2017) 130 (Supplement 1): 1828.

https://doi.org/10.1182/blood.V130.Suppl_1.1828.1828

Published: 2017

Journal Articles

Ahead Study: A 3 Year Follow-up of 522 Severe and Moderate Hemophilia a Patients

Johannes Oldenburg, Prof, Dimitrios Tsakiris, Prof, Cedric R. Hermans, MD PhD MRCP, RI Liesner, MD FRCP, FRCPath, MA, MBBChir, Kate Khair, Maria Gabriella Mazzucconi, Prof, Katharina N Steinitz-Trost, PhD, Gerald Spotts, PhD, Armin J Reininger, Prof, Alessandro Gringeri, MD MSc

Blood (2016) 128 (22): 3786.

https://doi.org/10.1182/blood.V128.22.3786.3786

Published: 2016

Journal Articles

Rviii-Singlechain Pharmacokinetics and Safety in Children Less Than 12 Years of Age

Claudia Djambas Khayat, MD BS, Oleksandra Stasyshyn, MD, Genadi Iosava, Prof., D.M., Ph. D., Jeannie B Ong, MD, Faraizah Abdul Karim, MD, Debra M. Bensen-Kennedy, MD, Katie St. Ledger, MS, Tharin Limsakun, PhD, Alex Veldman, MD, Ingrid Pabinger, MD

Blood (2015) 126 (23): 3524.

https://doi.org/10.1182/blood.V126.23.3524.3524

Published: 2015

Journal Articles

Evaluation Of The Pre-Transplantation Workup Before Allogeneic Transplantation and Reasons For Delaying Or Cancelling Transplant

Sabine Gerull, MD, Andreas S Buser, MD, Christoph Bucher, MD, Dominik Heim, MD, Michael Medinger, MD, Jakob Passweg, MD, Martin Stern, MD

Blood (2013) 122 (21): 5456.

https://doi.org/10.1182/blood.V122.21.5456.5456

Published: 2013

Journal Articles

Two-Year Renal Hemodynamic Effects of Deferasirox in Patients with Transfusion-Dependent β-Thalassemia

Antonio Piga, MD, Silvia Fracchia, MD, Maria Eliana Lai, MD, M Domenica Cappellini, MD, Dany Habr, MD, Antje Wegener, MD, Emmanuel Bouillaud, MSc, Gian Luca Forni, MD

Blood (2012) 120 (21): 3257.

https://doi.org/10.1182/blood.V120.21.3257.3257

Published: 2012

Journal Articles

Tolerability of 2-Weekly CHOP+Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan (Zevalin) In Patients with Previously Untreated Diffuse Large B Cell Lymphoma (DLBCL): Final Analysis

Andrew Manson, Reem Karmali, MD, Irene Dehghan-Paz, MD, Eduardo Braun, MD, Teresa O'Brien, Stephanie A. Gregory, MD, Jamile M. Shammo, MD, Melissa L Larson, MD, Parmeswaran Venugopal, MD

Blood (2010) 116 (21): 4918.

https://doi.org/10.1182/blood.V116.21.4918.4918

Published: 2010

Journal Articles

Infectious Complications After Unrelated Umbilical Cord Blood Transplantation (UCBT) in Adult Patients with Hematological Malignancies.

Xavier Cahu, Fanny Rialland, Cyrille Touzeau, Patrice Chevallier, MD, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Viviane Dubruille, Steven Le Gouill, MD, PhD, Beatrice Mahe, Thomas Gastinne, Nicolas Blin, Beatrice Saulquin, Jean-Luc Harousseau, Philippe Moreau, MD, Francoise Mechinaud, Mohamad Mohty, MD, PhD

Blood (2009) 114 (22): 1142.

https://doi.org/10.1182/blood.V114.22.1142.1142

Published: 2009

Journal Articles

Cumulative Efficacy and Safety of 5-Year Deferasirox (Exjade ® ) Treatment in Pediatric Patients with Thalassemia Major: A Phase II Multicenter Prospective Trial

Antonio Piga, Kamila Kebaili, Renzo Galanello, Valentine Jehl, Corinne Rebischung, Henry Maseruka, Lisa Rojkjaer, Gian Luca Forni

Blood (2008) 112 (11): 5413.

https://doi.org/10.1182/blood.V112.11.5413.5413

Published: 2008

Journal Articles

Allergen-Specific B Cell Quantity Is Similar in Allergic and Nonallergic Individuals, Whereas Allergen-Specific T Cells May Be Increased in Allergic Individuals

Faisal Khan, PhD, Aito Ueno-Yamanouchi, Bazir Serushago, MD, PhD, Tom Bowen, MD, Cathy Lu, Joanne Luider, Jan Storek, MD, PhD

Blood (2008) 112 (11): 4912.

https://doi.org/10.1182/blood.V112.11.4912.4912

Published: 2008

Journal Articles

Safety and Tolerability of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Amy D. Klion, MD, Marc E. Rothenberg, MD, PhD, John J. Murray, MD,PhD, Anish Singh, MD, PhD, Hans-Uwe Simon, MD,PhD

Blood (2006) 108 (11): 2694.

https://doi.org/10.1182/blood.V108.11.2694.2694

Published: 2006

Journal Articles

Rituximab Induced Interstitial Lung Disease.

Stephanie A. Wagner, MD, Samir S. Makani, MD, Damian A. Laber, MD, F.A.C.P.

Blood (2005) 106 (11): 4768.

https://doi.org/10.1182/blood.V106.11.4768.4768

Published: 2005

Journal Articles

Low Molecular Weight and Unfractionated Heparins Induce a down Regulation of Inflammation: Decreased Levels of Pro-Inflammatory Cytokines and Nuclear Factor-kB in LPS-Stimulated Human Monocytes.

Helene M. Hochart, Vincent P. Jenkins, Barry D. White

Blood (2005) 106 (11): 3884.

https://doi.org/10.1182/blood.V106.11.3884.3884

Published: 2005

NARROW

Deviation from Guidelines in Use of Eltrombopag and Romiplostim in Clinical Practice for Children with Primary Immune Thrombocytopenia; Multi-Center Egyptian Experience

Prevention and Management of Daratumumab Mediated Infusion Related Hypersensitivity Reactions Pre-and Post-Implementation of Rapid Infusion Protocol

Clinical and immunological features in a cohort of patients with partial DiGeorge syndrome followed at a single center

Updated Preliminary Results of a Phase 1b Dose Escalation and Dose Expansion Study of Tirabrutinib Alone or in Combination with Idelalisib or Entospletinib in Patients with Previously Treated Chronic Lymphocytic Leukemia

Immunodeficiency Caused Byheterozygous RAG1 Gene Mutation in a Boy Manifested As Severe Granulomatous Diseases and Eosinophilia: A Case Report

Daratumumab in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma (GEN503): Final Results of an Open-Label, Phase 1/2 Study

Ahead Study: A 3 Year Follow-up of 522 Severe and Moderate Hemophilia a Patients

Rviii-Singlechain Pharmacokinetics and Safety in Children Less Than 12 Years of Age

Evaluation Of The Pre-Transplantation Workup Before Allogeneic Transplantation and Reasons For Delaying Or Cancelling Transplant

Two-Year Renal Hemodynamic Effects of Deferasirox in Patients with Transfusion-Dependent β-Thalassemia

Tolerability of 2-Weekly CHOP+Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan (Zevalin) In Patients with Previously Untreated Diffuse Large B Cell Lymphoma (DLBCL): Final Analysis

Infectious Complications After Unrelated Umbilical Cord Blood Transplantation (UCBT) in Adult Patients with Hematological Malignancies.

Cumulative Efficacy and Safety of 5-Year Deferasirox (Exjade ® ) Treatment in Pediatric Patients with Thalassemia Major: A Phase II Multicenter Prospective Trial

Allergen-Specific B Cell Quantity Is Similar in Allergic and Nonallergic Individuals, Whereas Allergen-Specific T Cells May Be Increased in Allergic Individuals

Safety and Tolerability of Anti-IL-5 Monoclonal Antibody (Mepolizumab) Therapy in Patients with HES: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Rituximab Induced Interstitial Lung Disease.

Low Molecular Weight and Unfractionated Heparins Induce a down Regulation of Inflammation: Decreased Levels of Pro-Inflammatory Cytokines and Nuclear Factor-kB in LPS-Stimulated Human Monocytes.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only